Table 1.
Evolution of literature on ELS formulations and components⋆ considered in the mentioned reference.
Table 2.
Elements of the ELS model.
Table 3.
Characteristics of the computer used in the simulations.
Table 4.
Distributions and true parameters used in the simulation study.
Table 5.
Inventory model parameters for t = 1, 2, 3 periods of the decision stages.
Table 6.
Empirical mean, SD, CS, CK, median, and Friedman p-value of the for the indicated distribution, link, σ and percentile.
Table 7.
Evaluation of out-of-sample scenarios for the indicated distribution, link, σ and percentile with simulated data and the mentioned performance indicator.
Table 8.
Data set of monthly DPUTs of two pharmaceutical products.
Fig 1.
Histogram (A), box plots (B) and index-plot (C) of monthly DPUT; scatter-plot between DPUT and DPUT of the correlated pharmaceutical product (D); ACF (E) and PACF (F) plots of DPUT.
Table 9.
Descriptive statistics of monthly DPUT for the pharmaceutical product.
Table 10.
Criterion and deviance for different GARMA models with DPUT data of the pharmaceutical product.
Fig 2.
PP plot with 95% acceptance bands (A) and index-plot of the quantile residual (B) with DPUT data.
Table 11.
Effect of scenarios of DPUT percentiles using the indicated model on SP elements in two stages with DPUT data of the pharmaceutical product.
Table 12.
Evaluation of out-of-sample scenarios for the case study according to the mentioned performance indicator.